• 1.

    Nicolas D et al.2015. Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4. Expert Rev Anti Infect Ther 13: 947963.

    • Search Google Scholar
    • Export Citation
  • 2.

    Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL , 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24: 60586068.

    • Search Google Scholar
    • Export Citation
  • 3.

    Marinho J, Galvao-Castro B, Rodrigues LC, Barreto ML , 2005. Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case–control study. J Acquir Immune Defic Syndr 40: 625628.

    • Search Google Scholar
    • Export Citation
  • 4.

    de Lourdes Bastos M et al.2009. Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis. Int J Tuberc Lung Dis 13: 15191523.

    • Search Google Scholar
    • Export Citation
  • 5.

    Norrgren HR et al.2008. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. J Acquir Immune Defic Syndr 48: 607610.

    • Search Google Scholar
    • Export Citation
  • 6.

    Verdonck K et al.2007. HTLV-1 infection is frequent among out-patients with pulmonary tuberculosis in northern Lima, Peru. Int J Tuberc Lung Dis 11: 10661072.

    • Search Google Scholar
    • Export Citation
  • 7.

    Verdonck K, Gonzalez E, Schrooten W, Vanham G, Gotuzzo E , 2008. HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in Peru. Epidemiol Infect 136: 10761083.

    • Search Google Scholar
    • Export Citation
  • 8.

    Seaton RA, 1997. Tuberculosis and human T-cell lymphotropic virus type 1 infection. https://doi.org/10.1093/clinids/24.5.1026.

  • 9.

    Grassi MF et al.2016. Tuberculosis incidence in a cohort of individuals infected with human T-lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil. BMC Infect Dis 16: 491.

    • Search Google Scholar
    • Export Citation
  • 10.

    Gessain A, Cassar O , 2012. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3: 388.

  • 11.

    Eshima N et al.2009. Age and gender specific prevalence of HTLV-1. J Clin Virol 45: 135138.

  • 12.

    Allain JP et al.1992. Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians. J Acquir Immune Defic Syndr 5: 12301236.

  • 13.

    Schierhout G et al.2020. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis 20: 133143.

    • Search Google Scholar
    • Export Citation
  • 14.

    Journo C, Mahieux R, 2011. HTLV-1 and innate immunity. Viruses 3: 13741394.

  • 15.

    Carvalho NB et al.2018. Impaired TNF, IL-1β, and IL-17 production and increased susceptibility to Mycobacterium tuberculosis infection in HTLV-1 infected individuals. Tuberculosis (Edinb) 108: 3540.

    • Search Google Scholar
    • Export Citation
  • 16.

    Sia JK, Rengarajan J , 2019. Immunology of Mycobacterium tuberculosis infections. Microbiol Spectr 7: 10.

  • 17.

    Kohno T et al.2005. Possible origin of adult T-cell leukemia/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells. Cancer Sci 96: 527533.

    • Search Google Scholar
    • Export Citation
  • 18.

    Jasenosky LD, Scriba TJ, Hanekom WA, Goldfeld AE , 2015. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev 264: 7487.

    • Search Google Scholar
    • Export Citation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 

 

 

Prevalence of HTLV-I Infection and Its Association with Tuberculosis among Patients at an Urban Clinic in Haiti

View More View Less
  • 1 Center for Global Health, Weill Cornell Medicine, New York, New York;
  • | 2 Division of General Internal Medicine, Weill Cornell Medicine, New York, New York;
  • | 3 Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York;
  • | 4 GHESKIO Centers, Port-au-Prince, Haiti;
  • | 5 Brigham and Women’s Hospital, Boston, Massachusetts
Restricted access

ABSTRACT.

This retrospective case–control study examined the prevalence of HTLV-I and its association with tuberculosis among urban clinic patients in Haiti. Prevalence of HTLV-I among tuberculosis cases was 2.1% and among controls was 2.4%. Prevalence of HLTV-I was higher in females than males (odds ratio [OR] 2.45, P = 0.020). HTLV-I prevalence in those ≥ 50 years was 8.4% compared with 1.3% in those < 50 (OR 6.74, P < 0.001). We found no association between HTLV-I and tuberculosis in this population.

Author Notes

Address correspondence to Kathleen F. Walsh, Center for Global Health, Weill Cornell Medicine, 402 E 67th Street, 2nd Floor, New York City, NY 10065. E-mail: kfw2001@med.cornell.edu

Financial support: This work was supported by the National Institutes of Health grants K23-AI131913 (to K. M. D.), and U19-AI111143.

Authors’ addresses: Kathleen F. Walsh, Myung Hee Lee, Josef A. Brejt, Mary J. Reust, and Kathryn Dupnik, Weill Cornell Medicine, New York, NY, E-mails: kfw2001@med.cornell.edu, myl2003@med.cornell.edu, jab9179@med.cornell.edu, juliet319@gmail.com, and kd9040@med.cornell.edu. Marc Jean Juste, Genevieve Hilaire and Jean William Pape, GHESKIO Centers, Port-au-Prince, Haiti, E-mails: mjeanjuste@gheskio.org, gehissah@gmail.com, and jwpape@gheskio.org. Serena Koenig, Brigham and Women’s Hospital, Boston, MA, E-mail: skoenig@bwh.harvard.edu.

Save